KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Aurora Cannabis (ACB) EBITDA (2017 - 2025)

Aurora Cannabis has reported EBITDA over the past 9 years, most recently at -$681232.0 for Q4 2025.

  • Quarterly EBITDA fell 103.51% to -$681232.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$70.9 million through Dec 2025, down 910.11% year-over-year, with the annual reading at $3.4 million for FY2025, 74.92% down from the prior year.
  • EBITDA was -$681232.0 for Q4 2025 at Aurora Cannabis, up from -$38.6 million in the prior quarter.
  • Over five years, EBITDA peaked at $58.1 million in Q1 2021 and troughed at -$489.0 million in Q2 2022.
  • The 5-year median for EBITDA is -$7.2 million (2021), against an average of -$33.6 million.
  • Year-over-year, EBITDA plummeted 2140.82% in 2022 and then soared 275.18% in 2024.
  • A 5-year view of EBITDA shows it stood at -$5.6 million in 2021, then tumbled by 809.55% to -$51.3 million in 2022, then surged by 110.08% to $5.2 million in 2023, then soared by 275.18% to $19.4 million in 2024, then tumbled by 103.51% to -$681232.0 in 2025.
  • Per Business Quant, the three most recent readings for ACB's EBITDA are -$681232.0 (Q4 2025), -$38.6 million (Q3 2025), and -$14.8 million (Q2 2025).